SCHEMBL31095227

SCHEMBL31095227

N#Cc1ccc(Br)c(/C=C\c2cccnc2F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1A1 P48729 1/20 0.38
▸ CSNK1D P48730 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ CSNK1G2 P78368 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.36
▸ CYP11B2 P19099 2/20 0.35
▸ METAP2 P50579 1/20 0.33
▸ METAP1 P53582 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ EGLN2 Q96KS0 1/20 0.33
▸ RAD51 Q06609 1/20 0.33
▸ PDE2A O00408 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ TRIM24 O15164 1/20 0.32
▸ TRIM33 Q9UPN9 1/20 0.32
▸ CYP17A1 P05093 1/20 0.31
▸ CYP11B1 P15538 1/20 0.31
▸ NAPRT Q6XQN6 1/20 0.31
▸ GRM5 P41594 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31095177 0.81 NFE2L2 (0.42) CYP11B2PDE10ATRIM24TRIM33NAPRT
SCHEMBL31095224 0.77 HSD11B1 (0.43) TRIM24TRIM33NAPRT
SCHEMBL31095207 0.77 HSD11B1 (0.43) TRIM24TRIM33NAPRT
SCHEMBL8486922 0.74 NAPRT (0.48) TRIM24TRIM33NAPRT
SCHEMBL8486928 0.74 NAPRT (0.48) TRIM24TRIM33NAPRT
SCHEMBL31095221 0.72 NFE2L2 (0.42) CYP11B2METAP2METAP1PDE10ATRIM24
SCHEMBL4774408 0.71 HRH4 (0.41) HRH4RAD51
SCHEMBL4774403 0.71 HRH4 (0.41) HRH4RAD51
SCHEMBL31095230 0.68 NFE2L2 (0.47) TRIM24TRIM33NAPRT
SCHEMBL4769368 0.67 CYP2A6 (0.36) RAD51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680602-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS Miralinc Pharma, Inc. (US) 2026-01-21 — — EP disclosed
WO-2024192237-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS MIRALINC PHARMA, INC. (US) 2024-09-19 — — WO disclosed
Send feedback